Bone Biologics Corp (BBLG)
2.08
+0.04
(+1.96%)
USD |
NASDAQ |
Mar 28, 11:06
Bone Biologics Cash from Operations (TTM): -9.556M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -9.556M |
September 30, 2023 | -9.489M |
June 30, 2023 | -7.329M |
March 31, 2023 | -4.056M |
December 31, 2022 | -3.567M |
September 30, 2022 | -1.803M |
June 30, 2022 | -1.686M |
March 31, 2022 | -1.961M |
December 31, 2021 | -1.229M |
September 30, 2021 | -1.167M |
June 30, 2021 | -0.9619M |
March 31, 2021 | -0.405M |
December 31, 2020 | -0.4269M |
September 30, 2020 | -0.5989M |
June 30, 2020 | -1.001M |
March 31, 2020 | -2.472M |
December 31, 2019 | -3.251M |
Date | Value |
---|---|
September 30, 2019 | -4.292M |
June 30, 2019 | -5.098M |
March 31, 2019 | -4.215M |
December 31, 2018 | -4.105M |
September 30, 2018 | -3.698M |
June 30, 2018 | -2.978M |
March 31, 2018 | -3.141M |
December 31, 2017 | -3.330M |
September 30, 2017 | -3.666M |
June 30, 2017 | -4.611M |
March 31, 2017 | -5.809M |
December 31, 2016 | -7.328M |
September 30, 2016 | -7.071M |
June 30, 2016 | -6.605M |
March 31, 2016 | -5.581M |
December 31, 2015 | -3.546M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-9.556M
Minimum
Dec 2023
-0.405M
Maximum
Mar 2021
-3.228M
Average
-2.217M
Median
Cash from Operations (TTM) Benchmarks
Cingulate Inc | -16.68M |
Microbot Medical Inc | -9.175M |
First Wave BioPharma Inc | -14.53M |
Cytokinetics Inc | -414.33M |
Calidi Biotherapeutics Inc | -- |